A respectable move here. There's no doubt that CW has an amount of clout when it comes to sales so a move to CRO position is a positive one in my eyes.
Also gives the opportunity to recruit some new talent for the top job.
Given Mark Kehoe was in charge of commercialisation and produced little in way of results this seems a necessary step. Further cost savings on his salary and a reduction in CW's.. Not something you see every day so an appreciated move for sure.
Ann: CEO, Director and Senior Executive Update, page-5
Add ODE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.173M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 23036601 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 9595342 | 17 |
View Market Depth
| Last trade - 16.12pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
0.3¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 0.3¢ | 0.3¢ | 0.3¢ | 25000 | ||
| Last updated 13.05pm 06/06/2024 ? | |||||
| ODE (ASX) Chart |
Day chart unavailable